Assessment of Normal Value of Acoustic Radiation Force Impulse (ARFI) Elastography in HIV Patients
NCT01283243 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2012-02-02
Summary
This is a prospective cohort single center study for assessment of normal value of acoustic radiation force impulse elastography and fibroscan in HIV patients without abnormal liver function and chronic liver disease.
Conditions
- HIV Infection
Interventions
- DEVICE
-
Acoustic radiation force impulse imaging
Acoustic radiation force impulse (ARFI) imaging were measured 10 times in each patient.The region of interest was chosen in an area where the normal liver parenchyma was at least 6 cm thick and free of large blood vessels was chosen. A measurement depth of 2 cm below the liver capsule was chosen to standardize the examination.
Sponsors & Collaborators
-
Severance Hospital
collaborator OTHER -
Yonsei University
lead OTHER
Principal Investigators
-
Kwang-Hyub Han, MD · Yonsei University Colleage of Medicine
-
Seung Up Kim, MD · Yonsei University Colleage of Medicine
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-10-31
- Primary Completion
- 2012-06-30
- Completion
- 2012-06-30
Countries
- South Korea
Study Locations
More Related Trials
-
A Study of Tumor Necrosis Factor and Human Interferon-gamma in Patients With AIDS Related Complex
NCT00001004 ·Status: COMPLETED ·Phase: PHASE2
-
Cohort of Patients Naive of Antiretroviral Treatment at Enrollment
NCT03137797 ·Status: COMPLETED
-
Switching From TDF-based Antiretroviral Therapy Regimens to B/F/TAF in Virally Suppressed Adults With HIV-1 Infection
NCT05122754 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study
NCT01535235 ·Status: COMPLETED ·Phase: PHASE4
-
Preliminary Study of Early, Primary HIV Infection in a High Risk Cohort
NCT00989144 ·Status: COMPLETED
-
Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)
NCT00115609 ·Status: COMPLETED ·Phase: PHASE3
-
Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy
NCT01295515 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
NCT00488059 ·Status: TERMINATED ·Phase: PHASE4
-
Appropriate Timing of HAART in Co-infected HIV/TB Patients
NCT01014481 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
NCT01694420 ·Status: COMPLETED ·Phase: PHASE3
-
Renal Effect of Stribild or Other Tenofovir DF-containing Regimens Compared to Ritonavir-boosted Atazanavir Plus Abacavir/Lamivudine in Antiretroviral Treatment-naive HIV-1 Infected Adults
NCT02246998 ·Status: COMPLETED ·Phase: PHASE4
-
Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)
NCT00122551 ·Status: TERMINATED ·Phase: PHASE3
-
Dynamics of Drug Resistance-associated Mutations in HIV-1 DNA Reverse Transcriptase Clearance During Effective Antiretroviral Therapy
NCT04448158 ·Status: COMPLETED
-
A Study to Explore Reconstitution of Immunity in Patients With Advanced HIV-1-infection
NCT01296373 ·Status: COMPLETED
-
123I Radiolabeled 3BNC117
NCT03468582 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment
NCT01346878 ·Status: COMPLETED
-
A Study to Evaluate Efficacy and Safety of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (D/C/F/TAF) Fixed Dose Combination (FDC) Versus a Regimen Consisting of Darunavir/Cobicistat FDC With Emtricitabine/Tenofovir Disoproxil Fumarate FDC in Treatment-naive HIV Type 1 Infected Subjects
NCT02431247 ·Status: COMPLETED ·Phase: PHASE3
-
Empiric Treatment for Acute HIV in the ED
NCT03711253 ·Status: UNKNOWN ·Phase: PHASE4
-
An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART
NCT01541085 ·Status: COMPLETED
-
Addition of Raltegravir to Established Antiretroviral Suppressive Therapy
NCT01245101 ·Status: TERMINATED ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts
NCT01928407 ·Status: COMPLETED ·Phase: PHASE4
-
Raltegravir Switch Study to Reduce Liver Fibrosis Progression in HIV-Hepatitis C Co-infection
NCT01231685 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study of Raltegravir/Truvada Versus Efavirenz/Truvada for Adults With Acute IV-1 Infection
NCT00734344 ·Status: COMPLETED ·Phase: NA
-
Initiation of First-line Antiretroviral Treatment With TENOFOVIR ALAFENAMIDE - EMTRICITABINE - BICTEGRAVIR at the First Clinical Contact in France: Trial IMEA 055 - FAST
NCT03858478 ·Status: UNKNOWN ·Phase: PHASE4
-
Study to Evaluate Switching From an E/C/F/TAF Fixed-Dose Combination (FDC) Regimen or a TDF Containing Regimen to B/F/TAF FDC in Human Immunodeficiency Virus-1 (HIV-1) Infected Participants Aged ≥ 65 Years
NCT03405935 ·Status: COMPLETED ·Phase: PHASE3